


Kiniksa Announces FDA Approval of Arcalyst




US DATABASE STUDY OF CLINICAL BURDEN AND UNMET NEED IN RECURRENT PERICARDITIS




THE AUTOINFLAMMATORY SIDE OF RECURRENT PERICARDITIS: ENLIGHTENING THE PATHOGENESIS FOR A MORE RATIONAL TREATMENT



KINIKSA ANNOUNCES FDA APPROVAL OF ARCALYST ® (RILONACEPT) FOR RECURRENT PERICARDITIS



